P3 Health Partners Inc.
PIII
$10.19
$1.1012.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.16% | -3.93% | 6.87% | 25.58% | 15.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.16% | -3.93% | 6.87% | 25.58% | 15.22% |
| Cost of Revenue | -3.78% | -2.62% | 11.57% | 43.94% | 20.81% |
| Gross Profit | -68.27% | -81.62% | -89.92% | -535.83% | -47.84% |
| SG&A Expenses | -13.24% | -9.17% | 26.54% | -0.49% | -3.76% |
| Depreciation & Amortization | -2.81% | -2.26% | -2.22% | -0.22% | -0.40% |
| Other Operating Expenses | -75.65% | -796.20% | 1,234.18% | 245.47% | -68.84% |
| Total Operating Expenses | -5.01% | -4.86% | 21.89% | 47.53% | 17.24% |
| Operating Income | -8.90% | 13.10% | -103.00% | -234.68% | -48.98% |
| Income Before Tax | -49.91% | 9.17% | -84.43% | -188.68% | -1.64% |
| Income Tax Expenses | 104.65% | -48.21% | 180.25% | -975.00% | 328.32% |
| Earnings from Continuing Operations | -51.75% | 10.81% | -86.88% | -175.82% | -4.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 39.09% | -23.10% | 61.60% | 134.81% | -5.70% |
| Net Income | -69.40% | -9.52% | -130.21% | -249.82% | -22.45% |
| EBIT | -8.90% | 13.10% | -103.00% | -234.68% | -48.98% |
| EBITDA | -35.27% | 23.58% | -156.40% | -656.40% | -1,390.63% |
| EPS Basic | -41.66% | 20.11% | -127.68% | -146.76% | 3.67% |
| Normalized Basic EPS | -267.99% | -295.99% | -757.09% | -1,150.52% | -173.51% |
| EPS Diluted | 15.44% | 20.11% | 3.09% | -163.26% | -61.36% |
| Normalized Diluted EPS | -280.13% | -295.99% | -757.09% | -2,927.13% | -171.17% |
| Average Basic Shares Outstanding | 19.58% | 37.09% | 1.11% | 41.76% | 27.12% |
| Average Diluted Shares Outstanding | 15.77% | 37.09% | 1.11% | -47.33% | 31.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |